BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Endocrine gland cancer AND LDH AND Staging
22 results:

  • 1. Εmerging Biomarkers in the Diagnosis and Treatment of Testicular Tumors.
    Evmorfopoulos K; Vlachostergios PJ; Sountoulides P; Tzortzis V
    Curr Cancer Drug Targets; 2023; 23(11):858-867. PubMed ID: 36967458
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Testicular neoplasms: the interrelationships of serum levels of microRNA-371a-3p (M371) and classical tumor markers with histology, clinical staging, and age-a statistical analysis.
    Dieckmann KP; Dumlupinar C; Grobelny F; Utschig J; Klemke M; Ahmed Saad EM; Wülfing C; Pichlmeier U; Isbarn H; Belge G
    J Cancer Res Clin Oncol; 2023 Aug; 149(10):7079-7090. PubMed ID: 36869885
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. French AFU cancer Committee Guidelines - Update 2022-2024: testicular germ cell cancer.
    Murez T; Fléchon A; Branger N; Savoie PH; Rocher L; Camparo P; Neuville P; Ferretti L; Van Hove A; Roupret M
    Prog Urol; 2022 Nov; 32(15):1066-1101. PubMed ID: 36400478
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Serum tumour markers in germ cell tumours: From diagnosis to cure.
    Pedrazzoli P; Rosti G; Soresini E; Ciani S; Secondino S
    Crit Rev Oncol Hematol; 2021 Mar; 159():103224. PubMed ID: 33493632
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. [French ccAFU guidelines - update 2020-2022: testicular germ cell tumors].
    Murez T; Fléchon A; Savoie PH; Rocher L; Camparo P; Morel-Journel N; Ferretti L; Méjean A
    Prog Urol; 2020 Nov; 30(12S):S280-S313. PubMed ID: 33349427
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. 18F-FDG PET/CT for primary staging of patients with testicular germ cell tumors: the predictors of 18F-FDG PET positivity and prognostic value of PET derived metabolic parameters.
    Aydos U; Tahtaci G; Özgür Akdemir Ü; Özet A
    Nucl Med Commun; 2020 Nov; 41(11):1199-1209. PubMed ID: 32796455
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Ovarian Sertoli-Leydig Cell Tumors: Epidemiological, Clinical and Prognostic Factors.
    Castro BGR; Souza CP; Andrade CEMDC; Vieira MA; Andrade DAP; Reis RD
    Rev Bras Ginecol Obstet; 2019 Jul; 41(7):440-448. PubMed ID: 31344718
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Serum tumor markers and testicular germ cell tumors: a primer for radiologists.
    Marshall C; Enzerra M; Rahnemai-Azar AA; Ramaiya NH
    Abdom Radiol (NY); 2019 Mar; 44(3):1083-1090. PubMed ID: 30539249
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. [Analysis of proliferative lesions of haematopoietic and lymphoid tissue in the female productive tract].
    Chen DB; Zhang H; Zhang YH; Wang Y; Song QJ; Yang SM; Cui H; Zhao Y; Fang XZ; Shen DH
    Zhonghua Fu Chan Ke Za Zhi; 2018 Apr; 53(4):263-269. PubMed ID: 29747272
    [No Abstract]    [Full Text] [Related]  

  • 10. [CCAFU french national guidelines 2016-2018 on testicular germ cell tumors].
    Durand X; Fléchon A; Murez T; Rocher L; Camparo P; Morel-Journel N; Savoie PH; Ferretti L; Sèbe P; Méjean A
    Prog Urol; 2016 Nov; 27 Suppl 1():S147-S165. PubMed ID: 27846929
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. [CCAFU Recommendations 2013: Testicular germ cell cancer].
    Durand X; Rigaud J; Avancès C; Camparo P; Fléchon A; Murez T; Sèbe P; Culine S; Iborra F; Mottet N; Coloby P; Soulié M;
    Prog Urol; 2013 Nov; 23 Suppl 2():S145-60. PubMed ID: 24485289
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. [The role of tumour markers in diagnosis and management of testicular germ cell tumours].
    Krege S; Albers P; Heidenreich A
    Urologe A; 2011 Mar; 50(3):313-21. PubMed ID: 21327901
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. [Retroperitoneal surgery in the treatment of germ-cell tumors of the testis: retroperitoneal lymph node dissection (RPLND)].
    Nicolai N; Necchi A; Piva L; Stagni S; Catanzaro MA; Biasoni D; Milani A; Torelli T; Salvioni R
    Urologia; 2010; 77(2):84-7. PubMed ID: 20890864
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. New advances in clinical biomarkers in testis cancer.
    Favilla V; Cimino S; Madonia M; Morgia G
    Front Biosci (Elite Ed); 2010 Jan; 2(2):456-77. PubMed ID: 20036893
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. A large pelvic mass in an adolescent patient with granulomatous nephritis: case report and discussion of treatment challenges.
    Kakarla N; Boswell HB; Zurawin RK
    J Pediatr Adolesc Gynecol; 2006 Jun; 19(3):223-9. PubMed ID: 16731419
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Germ cell tumours of the testis.
    Gori S; Porrozzi S; Roila F; Gatta G; De Giorgi U; Marangolo M
    Crit Rev Oncol Hematol; 2005 Feb; 53(2):141-64. PubMed ID: 15661565
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. [Retroperitoneal lymphadenectomy for testicular cancer and genito-sexual conditions: retrospective study].
    Castelli E; Terrone C; De Luca S; Rossetti SR
    Prog Urol; 2000 Sep; 10(4):578-82. PubMed ID: 11064900
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Anthracycline-based chemotherapy of primary non-Hodgkin's lymphoma of the testis: the hellenic cooperative oncology group experience.
    Pectasides D; Economopoulos T; Kouvatseas G; Antoniou A; Zoumbos Z; Aravantinos G; Tsatalas C; Halikia A; Nikolaides C; Kiamouris C; Pappa E; Pavlidis N; Skarlos D; Fountzilas G; Dimopoulos MA
    Oncology; 2000 May; 58(4):286-92. PubMed ID: 10838493
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Serum tumour markers in testicular and extragonadal germ cell malignancies.
    Klepp O
    Scand J Clin Lab Invest Suppl; 1991; 206():28-41. PubMed ID: 1947758
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Serum lactic dehydrogenase: a tumor marker for dysgerminoma.
    Schwartz PE; Morris JM
    Obstet Gynecol; 1988 Sep; 72(3 Pt 2):511-5. PubMed ID: 3405571
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.